As it becomes evident that the microbiome exerts an influence on the human immune system, scientists have begun to ponder therapies that might act on intestinal microbes to reduce harmful inflammation. Roxanne Khamsi reports.

Join Our Team

We are working to provide doctors and patients with an entirely new option to treat human disease: medicines based on live bacterial consortia that can colonize the human intestine. We believe developing this new type of medicines takes careful science and the best brains in the fields of microbial ecology, immunology, bioinformatics, process development, and manufacturing, among others. If you find this as exciting as we do, we want to hear from you!